Meron Abraha
Hospitalist · Atlanta, GANPI 1528412558
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 37 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $297, more than ten times the $16 reported in 2021.
Across 37 payments — averaging $27.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$179
- Johnson & Johnson$173
- Boehringer Ingelheim$153
- AstraZeneca$95
- Smith+Nephew$90
- Melinta Therapeutics, LLC$61
- plus $263 from 9 others
What the payments were for
- Food & beverage$1,014100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 7 | $179 |
| Johnson & Johnson | 6 | $173 |
| Boehringer Ingelheim | 4 | $153 |
| AstraZeneca(2 entities) | 4 | $95 |
| Smith+Nephew | 2 | $90 |
| Melinta Therapeutics, LLC | 2 | $61 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $48 |
| Amgen | 2 | $45 |
| Abbott | 2 | $42 |
| Sanofi | 1 | $28 |
| Stryker | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Gilead | 1 | $19 |
| La Jolla Pharmaceutical Company | 1 | $15 |
How this compares
$1,014 in reported general payments places this provider in the 85th percentile of 812 hospitalist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $166 |
| Pantoprazole Sodium | 22 | $141 |
| Ciprofloxacin Hcl | 15 | $79 |
| Amlodipine Besylate | 11 | $24 |
| Oxycodone Hcl | 11 | $19 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Atlanta
- Emilio LacayoAtlanta$9K
- Mukesh KumarAtlanta$6K
- Amaka EzimoraAtlanta$6K
- Pramod KakaralaAtlanta$5K
- Majid SheikhAtlanta$4K
- Richard RamonellAtlanta$4K
- Manpreet MalikAtlanta$4K
- Pranay PrabhakarAtlanta$4K
- Anup PatelAtlanta$3K
- Nnaemeka OkaroAtlanta$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.